In addition to NK cells, inhibition of NKG2A has also been shown to enhance the efficacy of cancer vaccines in murine tumor models via CD8+ T cell activation (58) and therefore selinexor mediated HLA-E downregulation may also promote T cell activity. This evidence concerns the gene KLRC1 and neoplasm.